Jpmorgan Chase & CO Utah Medical Products Inc Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Utah Medical Products Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 62,766 shares of UTMD stock, worth $4.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,766
Previous 72,552
13.49%
Holding current value
$4.06 Million
Previous $5.16 Million
18.72%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding UTMD
# of Institutions
102Shares Held
1.98MCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny227KShares$14.7 Million0.03% of portfolio
-
Black Rock Inc. New York, NY197KShares$12.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA179KShares$11.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX170KShares$11 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA117KShares$7.53 Million0.1% of portfolio
About UTAH MEDICAL PRODUCTS INC
- Ticker UTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 3,625,200
- Market Cap $234M
- Description
- Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...